Neuroprotective Agents: all 944 studies that test it
Page 9 of 10. Open to participants first (166), then studies with results posted, then the rest; newest registration first within each.
- Combined Treatment With Alteplase (Rt-PA) and Cerebrolysin® in Acute Ischemic Hemispheric StrokeCompletedNCT00840671Phase 3
- Study of Cilostazol and Probucol Alone and in Combination on Atherosclerosis Related Biomarker---atherosclerosis Cerebral Infarction Patient as Study SubjectCompletedNCT00823875Phase 4
- Study of Cilostazol and Probucol to Assess Their Effects on Atherosclerosis Related BiomarkerCompletedNCT00823849Phase 4
- Steroid Injection Treatment of Carpal Tunnel SyndromeCompletedNCT00806871Phase 2/3
- Assessment of the Operative Course in Connection With Removal of Lower Third MolarsCompletedNCT00805298Not applicable
- Efficacy Study of Tempol to Prevent Hair Loss From Radiotherapy to the BrainStatus unknownNCT00801086Phase 2
- The Efficacy of CILostazol ON Ischemic Complications After DES ImplantationCompletedNCT00776828Phase 4
- Study to Evaluate the Efficacy of Riluzole in Children and Young Adults With Spinal Muscular Atrophy (SMA)CompletedNCT00774423Phase 2/3
- A Mono-center Study in Healthy Volunteers on the Comparative Bioavailability of Pletal 100 mg Tablets and a New Pletal 100 mg Orodispersible Tablet (ODT), This Latter in Fasting Conditions With and Without Water and Under Fed ConditionsCompletedNCT00773630Phase 1
- Study of Rivastigmine to Treat Parkinsonian Apathy Without DementiaCompletedNCT00767091Phase 3
- Cilostazol Stroke Prevention Study : A Placebo-controlled Double-blind Trial for Secondary Prevention of Cerebral Infarction.CompletedNCT00766545Phase 3
- Chronotherapy in Acute Multiple Sclerosis (MS) AttackTerminatedNCT00764413Not applicable
- Signaling Mechanisms and Vascular Function in Patients With Diabetes MellitusCompletedNCT00762671Phase 2/3
- Rasagiline and Apathy in Parkinson's DiseaseCompletedNCT00755027Phase 4
- Oral Corticotherapy in Megadoses to Treat Multiple Sclerosis During RelapseCompletedNCT00753792Phase 4
- Rescue of Steroidogenic Capacity in Adrenocortical Failure Study (RADS)CompletedNCT00753597Phase 4
- Efficacy of Rivastigmine in Patients With Down SyndromeCompletedNCT00748007Not applicable
- Compliance and Tolerability of Rivastigmine Transdermal Patch 10 cm² in Patients With Probable Alzheimer's Disease.CompletedNCT00731224Phase 4
- Vasopressin, Epinephrine, and Steroids for Cardiac ArrestCompletedNCT00729794Phase 3
- Safety and Preliminary Efficacy Study of MTS-01 for the Prevention of Alopecia Induced by WHole Brain RadiotherapyTerminatedNCT00713154Phase 2
- Rivastigmine for Intensive Care Unit (ICU) DeliriumTerminatedNCT00704301Phase 4
- The Effects of Rasagiline on Cognitive Deficits Associated With Parkinson's DiseaseStatus unknownNCT00696215Phase 4
- A Pilot Trial of Pediatric Liver Transplantation Without SteroidsTerminatedNCT00694408Phase 3
- Corticosteroids for Cancer PainCompletedNCT00676936Phase 3
- RIVastigmine In Vascular cognitivE ImpairmentCompletedNCT00669344Phase 4
- Riluzole in Treating Patients With Stage III or Stage IV Melanoma That Can Be Removed by SurgeryTerminatedNCT00667901Phase 1
- Fasting Study of Cilostazol Tablets 100 mg and Pletal® Tablets 100 mgCompletedNCT00648388Phase 1
- Rivastigmine in Mild Alzheimer's Disease, FMRI StudyCompletedNCT00627848Not applicable
- A Double-Blind, Placebo-controlled Crossover Study of Repeat Rivastigmine Administration in Healthy Male VolunteersCompletedNCT00624663Not applicable
- The Comparison of Effects Between Increased Dose of Clopidogrel and Addition of CilostazolCompletedNCT00620646Not applicable
- The Role of Tea Catechins and Caffeine in Relation to Energy MetabolismCompletedNCT00611416Not applicable
- Bioequivalency Study of 50 mg Cilostazol Tablets Under Fasting ConditionsCompletedNCT00602407Not applicable
- Bioequivalency Study of 100 mg Cilostazol Tablets Under Fasting ConditionsCompletedNCT00602173Not applicable
- Methylphenidate, Rivastigmine or Haloperidol in Hypoactive Delirium in Intensive Care PatientsTerminatedNCT00599287Phase 3
- Triple Versus Dual Antiplatelet Therapy After ABT578-Eluting StentCompletedNCT00589927Phase 4
- Effects of Cilostazol on Plasma Adipocytokine and Arterial StiffnessStatus unknownNCT00573950Phase 4
- Efficacy and Safety of Piracetam Taken for 12 Months in Subjects Suffering From Mild Cognitive Impairment (MCI)CompletedNCT00567060Not applicable
- Steroids in Patients With Early ARDSStatus unknownNCT00562835Phase 2/3
- High-dose Methylprednisolone and Rituximab in High Risk B-CLLCompletedNCT00558181Phase 2
- Safety and Pharmacokinetics of Probucol and CilostazolCompletedNCT00549978Phase 4
- CARE Canadian ALS Riluzole EvaluationCompletedNCT00542412Phase 4
- Evaluation of Adhesion and Dermal Tolerability of EMSAMCompletedNCT00531596Phase 4
- Sunphenon Epigallocatechin-gallate (EGCg) in Relapsing-remitting Multiple Sclerosis (SuniMS Study)CompletedNCT00525668Phase 1/2
- Efficacy Study for Treatment of Dementia in Progressive Supranuclear PalsyStatus unknownNCT00522015Phase 2
- Is IFN-beta Treatment in MS Useful After a Washout Period in Patients With Neutralizing Antibodies to Interferon BetaCompletedNCT00493116Phase 4
- Investigating if Interferon-Beta Can be Used in Patients With MS After They Have Developed Neutralizing AntibodiesCompletedNCT00492466Phase 4
- Effect of Epigallocatechin-Gallate on Inner Retinal Function in Ocular Hypertension and Early GlaucomaStatus unknownNCT00476138Phase 1/2
- Efficacy of Selegiline in Negative Symptoms of SchizophreniaCompletedNCT00456976Early Phase 1
- Corticosteroids in Prevention of Facial Palsy After Cranial Base SurgeryCompletedNCT00438087Phase 3
- Effect of EGCG on the Body's Response to InsulinWithdrawnNCT00434499Phase 2
- Effects of Cilostazol on VEGF and Oxidative Stress Biomarkers in Hemodialysis Patients With Peripheral Vascular DiseaseCompletedNCT00431249Phase 4
- Steroids In caRdiac Surgery Trial (SIRS Trial)Status unknownNCT00427388Phase 4
- Triple Versus Dual Antiplatelet Therapy in Patients Undergoing Coronary Stent ImplantationCompletedNCT00404716Phase 4
- A Non-Blinded Study Demonstrating the Effectiveness and Safety of Azilect Alone or in Combination Therapy in Parkinson's DiseaseCompletedNCT00399477Phase 4
- A Comparison of Methotrexate Alone or Combined to Infliximab or to Pulse Methylprednisolone in Early Rheumatoid Arthritis: A Magnetic Resonance Imaging StudyCompletedNCT00396747Phase 4
- Testing a Full Substitution Therapy Approach As Treatment of Tobacco DependenceTerminatedNCT00390923Not applicable
- Laboratory-Treated Lymphocyte Infusion After Haploidentical Donor Stem Cell TransplantCompletedNCT00376480Phase 1
- A Randomized Study of IVIG vs. IVIG With High Dose Methylprednisolone in Childhood ITP.CompletedNCT00376077Phase 3
- Treatment of Refractory Schizophrenia With RiluzoleCompletedNCT00375050Not applicable
- Safety and Efficacy Study of Salvage Chemotherapy (R-ESHAP) to Treat Relapsed and Refractory Aggressive Non-Hodgkin's LymphomaTerminatedNCT00367497Phase 2
- Study of the Clinical and Biological Efficacity of NAAXIA SINE® in Vernal KeratoconjunctivitisCompletedNCT00357019Phase 4
- Combination Chemotherapy Followed by Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin's LymphomaWithdrawnNCT00310128Phase 2
- Steroid Withdrawal in Pediatric Renal Transplant Recipients Under Cyclosporine (CyA) and Mycophenolate Mofetil (MMF)CompletedNCT00309218Phase 3
- Treatment of Necrotizing Vasculitides for Patients Older Than 65 YearsCompletedNCT00307671Phase 4
- Does a Single Steroid Injection Reduce the Formation of Postmastectomy SeromaStatus unknownNCT00307606Phase 4
- Safety and Tolerability of Rivastigmine With Add-on Memantine in Patients With Probable Alzheimer's DiseaseCompletedNCT00305903Phase 4
- Early Low Dose Steroid Therapy of Acute Respiratory Distress SyndromeCompletedNCT00290602Phase 2
- Urinary Aquaporin 2 Excretion After Methylprednisolone in Fasting Healthy HumansCompletedNCT00281710Phase 4
- Riluzole in Huntington's DiseaseCompletedNCT00277602Phase 3
- Hemodynamic and Headache-Inducing Effect of Intravenous Vasoactive Intestinal Peptide in MigraineursCompletedNCT00272896Not applicable
- The Use of Cilostazol in Patients With Diabetic NephropathyCompletedNCT00272831Phase 4
- Cilostazol in Acute Ischemic Stroke Treatment (CAIST)CompletedNCT00272454Phase 4
- Experimental Headache Induced by Vasoactive Intestinal PolypeptideCompletedNCT00255320Not applicable
- Efficacy of Cyclophosphamide Versus Methylprednisolone in Patients With Secondary Progressive Multiple SclerosisCompletedNCT00241254Phase 3
- Rivastigmine Monotherapy and Combination Therapy With Memantine in Patients With Moderately Severe Alzheimer's Disease Who Failed to Benefit From Previous Cholinesterase Inhibitor TreatmentCompletedNCT00234637Phase 4
- Treatment of Orthostatic Hypotension in Autonomic FailureCompletedNCT00223691Phase 1
- An Extension Study Evaluating the Efficacy and Safety of Rivastigmine in Patients With Traumatic Brain Injury (TBI) With Persistent Cognitive DeficitsCompletedNCT00219245Phase 4
- An Open-label Extension to Evaluate the Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's DiseaseCompletedNCT00219232Phase 3
- Effectiveness of Selegiline in Treating Marijuana Dependent Individuals - 1CompletedNCT00218517Phase 2
- Neuroprotection and Natural History in Parkinson's Plus Syndromes (NNIPPS)TerminatedNCT00211224Phase 3
- Rasagiline in Advanced Parkinson's Disease Patients With Motor Fluctuations Treated With Levodopa/Carbidopa Therapy.CompletedNCT00203177Phase 3
- Study to Evaluate the Safety and Tolerability of Rasagiline in Advanced Parkinson's Disease PatientsCompletedNCT00203164Phase 3
- Safety, Tolerability, and Effectiveness of Rasagiline Mesylate in Patients With Parkinson's DiseaseCompletedNCT00203138Phase 3
- A Study to Evaluate the Effects of Tyramine in Patients Who Completed the PRESTO Study.CompletedNCT00203125Phase 3
- Effectiveness, Tolerability and Safety of Rasagiline in Early Parkinson's Disease Patients Not Treated With LevodopaCompletedNCT00203060Phase 3
- Multicenter Study of Rasagiline in Parkinson's Disease Patients Using Levodopa and Experiencing Motor FluctuationsCompletedNCT00203034Phase 3
- Effect of Riluzole as a Symptomatic Approach in Patients With Chronic Cerebellar AtaxiaCompletedNCT00202397Phase 2
- Efficacy and Safety Study of Cilostazol to Prevent Reoccurrence of StrokeCompletedNCT00202020Phase 3
- Prevention of Post-Extubation Laryngeal Edema With Intravenous CorticosteroidsCompletedNCT00199576Phase 3
- Piracetam for Treatment Tardive DyskinesiaCompletedNCT00190008Phase 3
- Efficacy and Safety of Rivastigmine in Patients With Traumatic Brain Injury and Cognitive ImpairmentCompletedNCT00171795Phase 3
- Rivastigmine For Methamphetamine Dependent IndividualsCompletedNCT00158210Phase 1
- Edaravone and Argatroban Stroke Therapy Study for Acute Ischemic StrokeCompletedNCT00153946Phase 4
- Dexamethasone Versus Methylprednisolone for the Treatment of Active Inflammatory Bowel DiseaseTerminatedNCT00152620Not applicable
- Efficacy and Safety of Rivastigmine in Patients With Mild Cognitive ImpairmentTerminatedNCT00134953Phase 3
- Claudication: Exercise Versus Endoluminal Revascularization (CLEVER)Status unknownNCT00132743Phase 3
- Rivastigmine Capsules in Patients With Probable Vascular DementiaCompletedNCT00130338Phase 3
- Dexanabinol in Severe Traumatic Brain InjuryCompletedNCT00129857Phase 3
- 6-Methyl-Prednisolone for Multiple Organ Dysfunction SyndromeStatus unknownNCT00127985Phase 4
- AVONEX® Combination Trial - "ACT"CompletedNCT00112034Phase 4